Ozone therapy in orthopaedics 10 marks pg answer with flow chart and images
ozone therapy orthopaedics musculoskeletal
ozone therapy orthopaedics mechanism applications clinical uses 10 marks
https://pmc.ncbi.nlm.nih.gov/articles/PMC11290204
ozone therapy intervertebral disc herniation lumbar
ozone therapy knee osteoarthritis intra-articular
PMID: 38905033
PMID: 39579218
ozone therapy orthopaedics flowchart mechanism diagram ozone disc herniation osteomyelitis images
Medical flowchart titled "Ozone Therapy in Orthopaedics - Clinical Decision Algorithm". Clean, professional medical flowchart with the following flow: Top box: "Patient with Orthopaedic Condition" → Diamond: "Condition Type?" with 4 branches: 1) Disc Herniation/LBP → "Intradiscal/Paravertebral Injection O3 (20-30 mcg/mL)" → "Ozone shrinks NP, reduces inflammation" → "Pain relief, avoid surgery"; 2) Knee OA → "Intra-articular Injection O3 (10-20 mcg/mL) ± Hyaluronic acid" → "Reduces IL-1β, TNF-α, MMP" → "Comparable to HA injection"; 3) Chronic Osteomyelitis → "Ozonated water lavage + VSD" → "Antimicrobial, promotes granulation" → "Bacterial clearance"; 4) Soft tissue (tendinopathy/fasciitis) → "Peritendinous/IM injection" → "Reduces ROS, anti-inflammatory" → "Improved function". Bottom section showing "Ozone Mechanisms" with 6 boxes: Anti-inflammatory, Antimicrobial, Improved oxygenation, Antioxidant regulation, Immune modulation, Tissue healing. Color scheme: navy blue headers, light green boxes, white background, medical style.

| Route | Concentration | Indication |
|---|---|---|
| Intradiscal | 15-30 mcg/mL | Lumbar disc herniation |
| Paravertebral/Epidural | 5-15 mcg/mL | Radiculopathy, LBP |
| Intra-articular | 10-20 mcg/mL | Knee OA, TMJ |
| Intramuscular (trigger point) | 5-15 mcg/mL | Myofascial pain, tendinopathy |
| Peritendinous | 5-10 mcg/mL | Tendinitis, fasciitis |
| Topical (ozonated water/oil) | - | Wounds, osteomyelitis |
| Major autohemotherapy (MAH) | 20-40 mcg/mL | Systemic effects, chronic pain |
| Minor autohemotherapy (MiAH) | 10-20 mcg/mL | Systemic immune modulation |
| Rectal insufflation | 10-30 mcg/mL | Systemic, chronic disease |

| Condition | Route | Notes |
|---|---|---|
| Lateral epicondylitis (Tennis elbow) | Perilesional injection | Reduces inflammation at enthesis |
| Plantar fasciitis | Peritendinous injection | Comparable to corticosteroids |
| De Quervain's tenosynovitis | Local injection | Case series evidence |
| Carpal tunnel syndrome | Local infiltration | Reduces inflammatory mediators |
| Myofascial pain / Trigger points | IM injection | Disrupts pain-spasm cycle |
| Spondylolisthesis / Spondylolysis | Paravertebral | Combined with rehabilitation |

| Absolute | Relative |
|---|---|
| Glucose-6-phosphate dehydrogenase (G6PD) deficiency | Hyperthyroidism |
| Pregnancy | Active hemorrhage |
| Thrombocytopenia | Severe cardiovascular disease |
| Hypersensitivity to ozone | Coagulation disorders |
| Active seizure disorder | Immunosuppression |
| Ozone Therapy | vs. Conventional |
|---|---|
| Minimally invasive | vs. Open surgery |
| No systemic side effects | vs. Long-term NSAIDs/steroids |
| Day care procedure | vs. Hospitalization |
| Addresses disc, joint, soft tissue | Multitarget mechanism |
| Cost-effective | vs. Surgical interventions |
| Can be repeated | vs. Corticosteroid limits |
| Condition | Route | O3 Concentration | Evidence Level |
|---|---|---|---|
| Lumbar disc herniation | Intradiscal | 20-30 mcg/mL | Level I (Meta-analysis) |
| Knee OA | Intra-articular | 10-20 mcg/mL | Level I (Meta-analysis) |
| Chronic osteomyelitis | Topical/irrigation | Ozonated water | Level III-IV |
| Cervical radiculopathy | Periradicular | 5-15 mcg/mL | Level II-III |
| Tendinopathy | Peritendinous | 5-10 mcg/mL | Level III-IV |
| Chronic wounds | Topical | Ozonated oil/water | Level II-III |